用trastuzumab治疗的HER2突变的复发性转移性皮肤状细胞癌病例
Yae Kye1, Joseph Marshalek2, Dalton Wise3
1Department of Internal Medicine Harbor-UCLA Torrance California USA.
Clinical case reports
|September 2, 2025
概括
转移性状细胞癌 (SCC) 的治疗可能具有挑战性. 在发现ERBB2 (HER2) 突变后,一个晚期SCC患者对HER2向治疗反应良好,这表明HER2是潜在的治疗向.
科学领域:
- 癌症学
- 皮肤病学
- 分子生物学
背景情况:
- 皮肤状细胞癌 (SCC) 是一种常见的皮肤癌.
- 由于化学疗法的反应不佳,晚期的SCC很难治疗.
- 在皮肤SCC中HER2的作用尚不清楚.
研究的目的:
- 报告具有ERBB2 (HER2) 突变的转移性SCC病例.
- 突出 HER2 向治疗在晚期 SCC 的潜力.
- 强调需要进一步研究HER2在皮肤SCC中的作用.
主要方法:
- 一个患有转移性SCC的病例报告.
- 审查患者的治疗史,包括手术,辐射和全身治疗.
- 基因分析显示ERBB2 (HER2) 突变.
- 开始 HER2 向治疗.
主要成果:
- 患者的转移性SCC中存在ERBB2 (HER2) 突变.
- 患者获得了显著且持续的治疗效果.
- 这表明HER2是晚期SCC的潜在驱动突变.
结论:
- 在ERBB2突变的晚期皮肤SCC患者中,针对HER2的治疗可能是有效的.
- HER2代表了晚期SCC的潜在治疗途径.
- 需要对HER家族在皮肤SCC中的作用进行进一步的研究.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659


